84 related articles for article (PubMed ID: 24057756)
1. The prevalence of neutralising antibodies to chimpanzee adenovirus type 6 and type 7 in healthy adult volunteers, patients with chronic hepatitis B and patients with primary hepatocellular carcinoma in China.
Jian L; Zhao Q; Zhang S; Huang W; Xiong Y; Zhou X; Jia B
Arch Virol; 2014 Mar; 159(3):465-70. PubMed ID: 24057756
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults.
Zhang S; Huang W; Zhou X; Zhao Q; Wang Q; Jia B
J Med Virol; 2013 Jun; 85(6):1077-84. PubMed ID: 23588735
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients.
Zhao H; Xu C; Luo X; Wei F; Wang N; Shi H; Ren X
Front Immunol; 2018; 9():335. PubMed ID: 29563911
[TBL] [Abstract][Full Text] [Related]
4. Neutralizing antibodies against adenovirus type 2 in normal and HIV-1-infected subjects: Implications for use of Ad2 vectors in vaccines.
Li Q; Liu Q; Huang W; Song A; Zhao C; Wu J; Wang Y
Hum Vaccin Immunother; 2017 Jun; 13(6):1-8. PubMed ID: 28301274
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of adenovirus type 5 neutralizing antibodies in healthy people and AIDS patients in Guangzhou, southern China.
Sun C; Zhang Y; Feng L; Pan W; Zhang M; Hong Z; Ma X; Chen X; Chen L
Vaccine; 2011 May; 29(22):3837-41. PubMed ID: 21447314
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of neutralizing antibodies to human adenovirus type 5 in healthy adults in China.
Yu B; Zhou Y; Wu H; Wang Z; Zhan Y; Feng X; Geng R; Wu Y; Kong W; Yu X
J Med Virol; 2012 Sep; 84(9):1408-14. PubMed ID: 22825819
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae.
Chen H; Xiang ZQ; Li Y; Kurupati RK; Jia B; Bian A; Zhou DM; Hutnick N; Yuan S; Gray C; Serwanga J; Auma B; Kaleebu P; Zhou X; Betts MR; Ertl HC
J Virol; 2010 Oct; 84(20):10522-32. PubMed ID: 20686035
[TBL] [Abstract][Full Text] [Related]
8. Neutralizing antibodies to human and simian adenoviruses in humans and New-World monkeys.
Ersching J; Hernandez MI; Cezarotto FS; Ferreira JD; Martins AB; Switzer WM; Xiang Z; Ertl HC; Zanetti CR; Pinto AR
Virology; 2010 Nov; 407(1):1-6. PubMed ID: 20797754
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of neutralizing antibodies against adenovirus type 14 and 55 in healthy adults in Southern China.
Zheng X; Rong X; Feng Y; Sun X; Li L; Wang Q; Wang M; Liu W; Li C; Yang Y; Zhou R; Lu J; Feng L; Chen L
Emerg Microbes Infect; 2017 Jun; 6(6):e43. PubMed ID: 28588291
[TBL] [Abstract][Full Text] [Related]
10. The sero-prevalence of anti-adenovirus 5 neutralizing antibodies is independent of a chronic hepatitis B carrier state in China.
Huang D; Hennequi M; Elvachev A; Menguy T; Silvestre N; Yu D; Han Y; Inchauspé G; Zhang X; Zhu R
Arch Virol; 2015 Apr; 160(4):1125-30. PubMed ID: 25616844
[TBL] [Abstract][Full Text] [Related]
11. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of neutralizing antibodies against AAV serotype 1 in healthy subjects in China: implications for gene therapy and vaccines using AAV1 vector.
Liu Q; Huang W; Zhao C; Zhang L; Meng S; Gao D; Wang Y
J Med Virol; 2013 Sep; 85(9):1550-6. PubMed ID: 23852678
[TBL] [Abstract][Full Text] [Related]
13. Seroepidemiological investigation of HAdV-4 infection among healthy adults in China and in Sierra Leone, West Africa.
Wang B; Li J; Wu S; Chen Y; Zhang Z; Zhai Y; Guo Q; Zhang J; Song X; Zhao Z; Hou L; Chen W
Emerg Microbes Infect; 2018 Dec; 7(1):200. PubMed ID: 30514848
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of serum neutralizing antibodies to adenovirus type 5 (Ad5) and 41 (Ad41) in children is associated with age and sanitary conditions.
Yang WX; Zou XH; Jiang SY; Lu NN; Han M; Zhao JH; Guo XJ; Zhao SC; Lu ZZ
Vaccine; 2016 Nov; 34(46):5579-5586. PubMed ID: 27682509
[TBL] [Abstract][Full Text] [Related]
15. International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials.
Mast TC; Kierstead L; Gupta SB; Nikas AA; Kallas EG; Novitsky V; Mbewe B; Pitisuttithum P; Schechter M; Vardas E; Wolfe ND; Aste-Amezaga M; Casimiro DR; Coplan P; Straus WL; Shiver JW
Vaccine; 2010 Jan; 28(4):950-7. PubMed ID: 19925902
[TBL] [Abstract][Full Text] [Related]
16. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.
Chan HL; Hui AY; Wong ML; Tse AM; Hung LC; Wong VW; Sung JJ
Gut; 2004 Oct; 53(10):1494-8. PubMed ID: 15361502
[TBL] [Abstract][Full Text] [Related]
17. Type II ground-glass hepatocytes as a marker of hepatocellular carcinoma in chronic hepatitis B.
Mathai AM; Alexander J; Kuo FY; Torbenson M; Swanson PE; Yeh MM
Hum Pathol; 2013 Aug; 44(8):1665-71. PubMed ID: 23574780
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of neutralizing antibodies to adenovirus capsid proteins in human and animal sera.
Yu B; Dong J; Wang C; Zhan Y; Zhang H; Wu J; Kong W; Yu X
Virology; 2013 Mar; 437(2):118-23. PubMed ID: 23351390
[TBL] [Abstract][Full Text] [Related]
19. Profile, spectrum and significance of hepatitis B virus genotypes in chronic HBV-infected patients in Yunnan, China.
You J; Sriplung H; Chongsuvivatwong V; Geater A; Zhuang L; Huang JH; Chen HY; Yu L; Tang BZ
Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):271-9. PubMed ID: 18522881
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between serum hepatitis B virus DNA load and hepatocellular carcinoma in Qidong, China: a cohort follow-up study of 14 years].
Sun Y; Chen TY; Lu PX; Wang JB; Wu Y; Zhang QN; Qian GS; Tu H
Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(27):1874-7. PubMed ID: 23134955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
